NANT Homepage
NANT Homepage About Us How You Can Help NANT Trials Contact Us

Current NANT Consortium Clinical Trials

Click to get more information about each trial:

  • N2004-05: Neuroblastoma Biology Study
  • N2011-01: Randomized MIBG: 131I-MIBG Alone vs. 131I-MIBG with Vincristine and Irinotecan vs. 131I-MIBG with Vorinostat
  • N2011-04: Lenalidomide, Anti-GD2 Mab Ch14.18 and 13-Cis-Retinoic Acid in Recurrent or Resistant Neuroblastoma Patients
  • N2012-01: DFMO, Celecoxib with Cyclophosphamide and Topotecan for Patients with Relapsed or Refractory Neuroblastoma
  • N2013-02: Sorafenib with Cyclophosphamide and Topotecan for patients with Relapsed or Refractory Neuroblastoma
  • N2014-01: SF1126 for patients with Relapsed or Refractory Neuroblastoma
  • N2015-01: Neuroblastoma Precision Trial
  • N2015-02: Lorlatinib for patients with Relapsed or Refractory Neuroblastoma